A citation-based method for searching scientific literature

Hermann Koepsell. Handb Exp Pharmacol 2021
Times Cited: 12







List of co-cited articles
115 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Organic Cation Transporters in Health and Disease.
Hermann Koepsell. Pharmacol Rev 2020
104
75

Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice.
Nicole L Baganz, Rebecca E Horton, Alfredo S Calderon, W Anthony Owens, Jaclyn L Munn, Lora T Watts, Nina Koldzic-Zivanovic, Nathaniel A Jeske, Wouter Koek, Glenn M Toney,[...]. Proc Natl Acad Sci U S A 2008
122
41

Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.
A Bacq, L Balasse, G Biala, B Guiard, A M Gardier, A Schinkel, F Louis, V Vialou, M-P Martres, C Chevarin,[...]. Mol Psychiatry 2012
85
41



Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1).
Eugene C Chen, Natalia Khuri, Xiaomin Liang, Adrian Stecula, Huan-Chieh Chien, Sook Wah Yee, Yong Huang, Andrej Sali, Kathleen M Giacomini. J Med Chem 2017
34
33

Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity.
K K Filipski, R H Mathijssen, T S Mikkelsen, A H Schinkel, A Sparreboom. Clin Pharmacol Ther 2009
253
33

OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine.
Zhi-Jun Wang, Ophelia Q P Yin, Brian Tomlinson, Moses S S Chow. Pharmacogenet Genomics 2008
176
33

Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.
A E Busch, U Karbach, D Miska, V Gorboulev, A Akhoundova, C Volk, P Arndt, J C Ulzheimer, M S Sonders, C Baumann,[...]. Mol Pharmacol 1998
261
33


Organic Cation Transporter Expression and Function in the CNS.
Douglas H Sweet. Handb Exp Pharmacol 2021
10
40

Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice.
Vincent Vialou, Laure Balasse, Jacques Callebert, Jean-Marie Launay, Bruno Giros, Sophie Gautron. J Neurochem 2008
70
33

Brain Plasma Membrane Monoamine Transporter in Health and Disease.
Letícia S Vieira, Joanne Wang. Handb Exp Pharmacol 2021
5
80

The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects.
Ivy H Song, Jian Zong, Julie Borland, Fred Jerva, Brian Wynne, Maciej J Zamek-Gliszczynski, Joan E Humphreys, Gary D Bowers, Mike Choukour. J Acquir Immune Defic Syndr 2016
55
25

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.
Yan Shu, Steven A Sheardown, Chaline Brown, Ryan P Owen, Shuzhong Zhang, Richard A Castro, Alexandra G Ianculescu, Lin Yue, Joan C Lo, Esteban G Burchard,[...]. J Clin Invest 2007
620
25

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.
Y Shu, C Brown, R A Castro, R J Shi, E T Lin, R P Owen, S A Sheardown, L Yue, E G Burchard, C M Brett,[...]. Clin Pharmacol Ther 2008
329
25

Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters.
Barbara Grün, Michael K Kiessling, Jürgen Burhenne, Klaus-Dieter Riedel, Johanna Weiss, Geraldine Rauch, Walter E Haefeli, David Czock. Br J Clin Pharmacol 2013
45
25

Effect of plasma membrane monoamine transporter genetic variants on pharmacokinetics of metformin in humans.
Seol Ju Moon, Jaeseong Oh, Seung Hwan Lee, Yewon Choi, Kyung-Sang Yu, Jae-Yong Chung. Transl Clin Pharmacol 2018
8
37

OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics.
J Matthaei, D Kuron, F Faltraco, T Knoch, J N Dos Santos Pereira, M Abu Abed, T Prukop, J Brockmöller, M V Tzvetkov. Clin Pharmacol Ther 2016
60
25

Increased Systemic Exposure and Stronger Cardiovascular and Metabolic Adverse Reactions to Fenoterol in Individuals with Heritable OCT1 Deficiency.
Mladen V Tzvetkov, Johannes Matthaei, Sherin Pojar, Frank Faltraco, Sabrina Vogler, Thomas Prukop, Tina Seitz, Jürgen Brockmöller. Clin Pharmacol Ther 2018
42
25

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Gustav Ahlin, Johan Karlsson, Jenny M Pedersen, Lena Gustavsson, Rolf Larsson, Pär Matsson, Ulf Norinder, Christel A S Bergström, Per Artursson. J Med Chem 2008
131
25

Pharmacokinetic evaluations of the co-administrations of vandetanib and metformin, digoxin, midazolam, omeprazole or ranitidine.
Susanne Johansson, Jessica Read, Stuart Oliver, Mark Steinberg, Yan Li, Eleanor Lisbon, David Mathews, Philip T Leese, Paul Martin. Clin Pharmacokinet 2014
45
25

Assessment of Substrate-Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates.
Philip J Sandoval, Kimberley M Zorn, Alex M Clark, Sean Ekins, Stephen H Wright. Mol Pharmacol 2018
56
25

Genetic variants of the organic cation transporter 2 influence the disposition of metformin.
I S Song, H J Shin, E J Shim, I S Jung, W Y Kim, J H Shon, J G Shin. Clin Pharmacol Ther 2008
174
25

The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.
M V Tzvetkov, S V Vormfelde, D Balen, I Meineke, T Schmidt, D Sehrt, I Sabolić, H Koepsell, J Brockmöller. Clin Pharmacol Ther 2009
228
25

Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain.
Anne Amphoux, Vincent Vialou, Eva Drescher, Michael Brüss, Clotilde Mannoury La Cour, Catherine Rochat, Mark J Millan, Bruno Giros, Heinz Bönisch, Sophie Gautron. Neuropharmacology 2006
152
25

Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1.
Tina Seitz, Robert Stalmann, Nawar Dalila, Jiayin Chen, Sherin Pojar, Joao N Dos Santos Pereira, Ralph Krätzner, Jürgen Brockmöller, Mladen V Tzvetkov. Genome Med 2015
64
25


N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
Fabian Müller, Constanza A Pontones, Bertold Renner, Maren Mieth, Eva Hoier, Daniel Auge, Renke Maas, Oliver Zolk, Martin F Fromm. Eur J Clin Pharmacol 2015
60
25

Profiling solute carrier transporters in the human blood-brain barrier.
E G Geier, E C Chen, A Webb, A C Papp, S W Yee, W Sadee, K M Giacomini. Clin Pharmacol Ther 2013
81
25

Pharmacokinetic drug-drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus.
Julia Zack, Jolene Berg, Axel Juan, Nicola Pannacciulli, Martine Allard, Mildred Gottwald, Heather Zhang, Yongwu Shao, Ori Ben-Yehuda, Phil Jochelson. Clin Pharmacol Drug Dev 2015
17
25

Effects of a MATE protein inhibitor, pyrimethamine, on the renal elimination of metformin at oral microdose and at therapeutic dose in healthy subjects.
H Kusuhara, S Ito, Y Kumagai, M Jiang, T Shiroshita, Y Moriyama, K Inoue, H Yuasa, Y Sugiyama. Clin Pharmacol Ther 2011
148
25

Role of organic cation transporters (OCTs) in the brain.
Thomas Couroussé, Sophie Gautron. Pharmacol Ther 2015
45
25

Discovery of the ergothioneine transporter.
Dirk Gründemann, Stephanie Harlfinger, Stefan Golz, Andreas Geerts, Andreas Lazar, Reinhard Berkels, Norma Jung, Andrea Rubbert, Edgar Schömig. Proc Natl Acad Sci U S A 2005
335
25


Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviours.
T Lee Gilman, Christina M George, Melissa Vitela, Myrna Herrera-Rosales, Mohamed S Basiouny, Wouter Koek, Lynette C Daws. Eur J Neurosci 2018
13
25

Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter.
Rheaclare Fraser-Spears, Anwen M Krause-Heuer, Mohamed Basiouny, Felix P Mayer, Retrouvailles Manishimwe, Naomi A Wyatt, Jeremy C Dobrowolski, Maxine P Roberts, Ivan Greguric, Naresh Kumar,[...]. Eur J Pharmacol 2019
21
25

Cloning and characterization of two human polyspecific organic cation transporters.
V Gorboulev, J C Ulzheimer, A Akhoundova, I Ulzheimer-Teuber, U Karbach, S Quester, C Baumann, F Lang, A E Busch, H Koepsell. DNA Cell Biol 1997
506
25


Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice.
R Zwart, S Verhaagh, M Buitelaar, C Popp-Snijders, D P Barlow. Mol Cell Biol 2001
137
25


Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression.
Rebecca E Horton, Deana M Apple, W Anthony Owens, Nicole L Baganz, Sonia Cano, Nathan C Mitchell, Melissa Vitela, Georgianna G Gould, Wouter Koek, Lynette C Daws. J Neurosci 2013
54
25

Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin.
Eugene C Chen, Xiaomin Liang, Sook Wah Yee, Ethan G Geier, Sophie L Stocker, Ligong Chen, Kathleen M Giacomini. Mol Pharmacol 2015
68
25


Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance.
Maciej J Zamek-Gliszczynski, Mitchell E Taub, Paresh P Chothe, Xiaoyan Chu, Kathleen M Giacomini, Richard B Kim, Adrian S Ray, Sophie L Stocker, Jashvant D Unadkat, Matthias B Wittwer,[...]. Clin Pharmacol Ther 2018
110
16

Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells.
Masahiro Tsuda, Tomohiro Terada, Miki Ueba, Tomoko Sato, Satohiro Masuda, Toshiya Katsura, Ken-ichi Inui. J Pharmacol Exp Ther 2009
143
16


Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects.
Ariel R Topletz-Erickson, Anthony J Lee, JoAl G Mayor, Evelyn L Rustia, Layth I Abdulrasool, Amanda L Wise, Ben Dailey, Sharon DeChenne, Luke N Walker, Stephen C Alley,[...]. J Clin Pharmacol 2021
7
28

Pharmacokinetics and tolerability of vandetanib in Chinese patients with solid, malignant tumors: an open-label, phase I, rising multiple-dose study.
Li Zhang, Su Li, Yang Zhang, Jing Zhan, Ben-Yan Zou, Robert Smith, Paul D Martin, Yinrui Jiang, Hai Liao, Zhongzhen Guan. Clin Ther 2011
27
16

Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2).
Peng Zhu, Zhi Ye, Dong Guo, Zongping Xiong, Shiqiong Huang, Jun Guo, Wei Zhang, James E Polli, Honghao Zhou, Qing Li,[...]. Pharm Res 2018
20
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.